Naresh Kumar Peddi

Naresh Kumar Peddi

Active Director Director DIN 05355311
DIN 05355311 First appointment Apr 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 1 historical roles
Total affiliations 3 Since Apr 2012
Shareholding value •••• Premium profile

About Naresh Kumar Peddi

Data last updated:

Naresh Kumar Peddi is a Director at Sri Anantha Padmanabha Swamy Pharma Private Limited (since 2013) and Director at Brighid Biologicals Private Limited (since 2019). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹9.30 Cr; the largest is Sri Anantha Padmanabha Swamy Pharma Private Limited at ₹8.58 Cr (FY 2024). Earlier, Naresh Kumar Peddi was an Additional Director at Elixir Therapeutics Private Limited (from 2012).

DIN 05355311
Primary Designation Director
Industry Pharma
First Appointment 04 Apr 2012
Oldest Company Age 20 yrs
Largest company Sri Anantha Padmanabha Swamy Pharma Private Limited · ₹8.58 Cr (FY 2024)
Combined revenue ₹9.30 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Apr 20132013₹8.58 Cr (FY 2024)Active
Brighid Biologicals Private Limited U51909TG2019PTC136920
Director18 Nov 20192019₹72 Lakh (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Elixir Therapeutics Private Limited U24239TG2006PTC049366
Additional Director04 Apr 20122006Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Elixir Therapeutics Private Limited
Brighid Biologicals Private Limited
Sri Anantha Padmanabha Swamy Pharma Private Limited
Premium access

Shareholding and investment profile for Naresh Kumar Peddi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naresh Kumar Peddi

Naresh Kumar Peddi currently holds 2 directorships: Sri Anantha Padmanabha Swamy Pharma Private Limited (Director, since 07 Apr 2013, revenue ₹8.58 Cr (FY 2024)); Brighid Biologicals Private Limited (Director, since 18 Nov 2019, revenue ₹72 Lakh (FY 2024)).

Naresh Kumar Peddi was first appointed on 04 Apr 2012 as Additional Director at Elixir Therapeutics Private Limited. The most recent appointment on record is 18 Nov 2019 at Brighid Biologicals Private Limited.

The 2 current companies of Naresh Kumar Peddi that report revenue have a combined latest revenue of ₹9.30 Cr: Sri Anantha Padmanabha Swamy Pharma Private Limited ₹8.58 Cr (FY 2024); Brighid Biologicals Private Limited ₹72 Lakh (FY 2024).

Naresh Kumar Peddi held 1 earlier board appointment: Elixir Therapeutics Private Limited (Additional Director, from 04 Apr 2012).

The current boards of Naresh Kumar Peddi's companies include Alok Agarwal (Sri Anantha Padmanabha Swamy Pharma Private Limited), Bhaskar Karshikallam (Sri Anantha Padmanabha Swamy Pharma Private Limited), Peddi Jagadishwar (Sri Anantha Padmanabha Swamy Pharma Private Limited), Renu Goyal (Sri Anantha Padmanabha Swamy Pharma Private Limited), Vallabadas Satyanarayana Goud (Sri Anantha Padmanabha Swamy Pharma Private Limited), Sribhavya Gupta Kanduri (Brighid Biologicals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available